Articles published by Monopar Therapeutics Inc.
Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments
August 09, 2024
Via GlobeNewswire
Tickers
MNPR
Monopar Therapeutics Announces 1-for-5 Reverse Stock Split
August 09, 2024
Via GlobeNewswire
Tickers
MNPR
Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24
June 25, 2024
Via GlobeNewswire
Tickers
MNPR
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
April 16, 2024
Via GlobeNewswire
Tickers
MNPR
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients
April 10, 2024
Via GlobeNewswire
Tickers
MNPR
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments
March 28, 2024
Via GlobeNewswire
Tickers
MNPR
Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial
February 27, 2024
Via GlobeNewswire
Tickers
MNPR
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers
February 22, 2024
Via GlobeNewswire
Tickers
MNPR
Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments
November 09, 2023
Via GlobeNewswire
Tickers
MNPR
Via GlobeNewswire
Tickers
MNPR
Monopar to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
Via GlobeNewswire
Tickers
MNPR
Monopar Therapeutics Reports Second Quarter 2023 Financial Results and Recent Developments
August 10, 2023
Via GlobeNewswire
Tickers
MNPR
Monopar Provides Encouraging Camsirubicin Clinical Data Update
August 08, 2023
Via GlobeNewswire
Tickers
MNPR
Via GlobeNewswire
Tickers
MNPR
Via GlobeNewswire
Tickers
MNPR
Via GlobeNewswire
Tickers
MNPR
Monopar Therapeutics Reports First Quarter 2023 Financial Results and Recent Developments
May 11, 2023
Via GlobeNewswire
Tickers
MNPR
Via GlobeNewswire
Tickers
MNPR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.